Mps1-IN-1,
1125593-20-5,
1-(4-(4-(2-(Isopropylsulfonyl)phenylamino)-1H-pyrrolo[2,3-b]pyridin-6-ylamino)-3-methoxyphenyl)piperidin-4-ol,
1MPS1-IN-1,
1-[3-methoxy-4-[[4-(2-propan-2-ylsulfonylanilino)-1H-pyrrolo[2,3-b]pyridin-6-yl]amino]phenyl]piperidin-4-ol,
J-503190,
1-(4-((4-((2-(isopropylsulfonyl)phenyl)amino)-1H-pyrrolo[2,3-b]pyridin-6-yl)amino)-3-methoxyphenyl)piperidin-4-ol,
3gfw,
1Mps1-IN-1/,
MLS003230944,
GTPL9271,
SCHEMBL4051419,
CHEMBL1235786,
BDBM36485,
CHEBI:91379,
DTXSID60649015,
BCP27688,
3868AH,
ABP000741,
ZINC58661129,
CS-3776,
QC-8177,
RL00506,
NCGC00387463-01,
NCGC00387463-04,
HY-13298,
SMR001913509,
1-(3-methoxy-4-{[4-({2-[(1-methylethyl)sulfonyl]phenyl}amino)-1H-pyrrolo[2,3-b]pyridin-6-yl]amino}phenyl)piperidin-4-ol,
1-[3-Methoxy-4-({4-[2-(propane-2-sulfonyl)anilino]-1H-pyrrolo[2,3-b]pyridin-6-yl}amino)phenyl]piperidin-4-ol,
s22,
Mps1 inhibitor,
cc-569,
C28H33N5O4S,
NMJMRSQTDLRCRQ-UHFFFAOYSA-N,
ACN-052756,
B4907,
A11218,